La Profusa, a biotechnology company in San Francisco, has received $ 7.5 million in funding from #DARPA for the development of his proprietary technology on a tiny implantable biosensor: it's another plus for the constantly developing Super Soldiers.
Lenders aim to develop technologies that can provide real-time monitoring.
About what? Of the vital parameters of the soldiers, in order to improve the efficiency of the missions. The sensors, developed with a special "smart hydrogel" not dissimilar to that used for modern contact lenses, form a porous and biocompatible container capable of reacting to light to produce information on the concentration of specific biomarkers.
“The company's vision is to create, with a combination of sensor and software, a real dashboard capable of showing data on oxygen, glucose, lactates, urea and ions in real time,” he declares Ben Hwang, CEO of Profusa.
With a length of about 3-5mm and a diameter of 500 microns, each minisensor is a fiber designed to be biologically compatible with human tissues to provide monitoring for up to 2 years without deterioration or rejection.
A hand-held or wearable device equipped with an optical reader will receive the fluorescent signals from the biosensor, allowing the data to be read. There are many fields of use, from medical applications to military use: real-time reading of vital parameters can allow the user to make quicker and more useful decisions, improve their state of health or better manage chronic disorders such as dil Diabetes. The data can also be transmitted to medical centers authorized to receive and process them.